Addiction-related Effects of DOV 216,303 and Cocaine: A Comparative Study in the Mouse

Neuroscience

• Reuptake 100%
• Reuptake Inhibitor 100%
• Pharmacokinetics 100%
• Conditioned Place Preference 100%
• Serotonin 50%
• Nucleus Accumbens 50%
• Microdialysis 50%
• Treatment of Depression 50%
• Norepinephrine 50%
• Receptor Occupancy 50%
• Monoamines Receptor 50%

Keyphrases

• Cocaine 100%
• Addiction 100%
• DOV 216,303 100%
• Dopamine 27%
• Pharmacokinetic Profile 18%
• Hyperlocomotion 18%
• Effective Dose 18%
• Place Preference 18%
• Conditioned Place Preference 18%
• Triple Reuptake Inhibitor 18%
• Drug-induced 9%
• Future Therapeutics 9%
• Nucleus Accumbens 9%
• Addictive Drugs 9%
• Microdialysis 9%
• Dopamine Level 9%
• Depression Treatment 9%
• Reuptake 9%
• High Dose 9%
• Acute Administration 9%
• Noradrenaline 9%
• Mechanism of Action 9%
• Occupancy 9%
• Receptor Occupancy 9%
• Copyright 9%
• Monoamine Receptors 9%
• Dopamine Reuptake 9%
• Depression Model 9%
• Therapeutic Use 9%
• Dose-ranging 9%
• Adult Mice 9%
• Extracellular Concentration 9%
• Serotonin Reuptake 9%
• Self-administration 9%
• Brain Exposure 9%
• Abuse Potential 9%
• Low Potential 9%
• Plasma Exposure 9%
• Rewarding Effect 9%
• Preference Modeling 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse 100%
• Pharmacokinetics 66%
• Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor 66%
• Serotonin 33%
• Receptor 33%
• Noradrenalin 33%
• Monoamine 33%
• Microdialysis 33%
• Therapeutic Use 33%